Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Merit Medical Systems (MMSI)

Merit Medical Q4 revenue up 9.4% to $355.2 million; 2025 outlook issued

Positive Impact 3 of 5 earnings Written later

Merit Medical reported fourth-quarter and full-year 2024 results on February 25, 2025, with revenue up 9.4% in the quarter and 7.9% for the year. The company also issued 2025 guidance calling for revenue of $1.470 billion to $1.490 billion and non-GAAP earnings per share of $3.58 to $3.70, up 8% to 10% and 4% to 7% from 2024. GAAP earnings per share in the quarter slipped to $0.46 from $0.47 a year earlier.

Key points

  • Q4 2024 revenue was $355.2 million, up 9.4%; GAAP net income was $27.9 million, or $0.46 per diluted share, versus $0.47 a year earlier
  • Q4 2024 non-GAAP EPS was $0.93, up 25.8% from the prior year period
  • Full-year 2024 revenue was $1.357 billion, up 7.9%; GAAP EPS was $2.03 versus $1.62 in 2023
  • 2025 guidance: revenue of $1.470 billion to $1.490 billion and non-GAAP EPS of $3.58 to $3.70

The filing

CompanyMerit Medical Systems (MMSI)
Form8-K, current report
Filed with the SECFeb 25, 2025, 4:18 PM ET
Accession number0000856982-25-000012

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:05 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 25, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.